Tian An Medicare Limited will convene its Annual General Meeting at 11:00 a.m. on Monday, 18 May 2026, at Plaza 1-2, Basement 3, Novotel Century Hong Kong, 238 Jaffe Road, Wanchai, Hong Kong.
Key proposals:
1. Financial Statements • Shareholders will vote on adopting the audited financial statements and the directors’ and auditor’s reports for the year ended 31 December 2025.
2. Board Composition and Remuneration • Re-election of four directors: Mr. Lee Seng Hui, Mr. Guo Meibao, Mr. Mark Wong Tai Chun and Mr. Zhou Haiying. • Authorisation for the board to determine directors’ remuneration.
3. Auditor Re-appointment • Deloitte Touche Tohmatsu is nominated for re-appointment as external auditor, with remuneration to be set by the board.
4. General Mandates • Share issuance mandate: Authority for the board to allot and issue new shares or convertible securities up to 20% of the company’s issued share capital as at the AGM date. • Share buy-back mandate: Authority to repurchase shares on the Hong Kong Stock Exchange or other recognised exchanges up to 10% of issued share capital. • Extension mandate: Conditional approval to extend the 20% issuance limit by the number of shares actually repurchased under the 10% buy-back mandate.
Logistics and Voting Arrangements:
• The share register will be closed from 13 May 2026 to 18 May 2026 (both days inclusive); only shareholders on record by 4:30 p.m. on 12 May 2026 are entitled to attend and vote. • All resolutions will be decided by poll, with results disclosed on the websites of the Hong Kong Stock Exchange and the company. • Shareholders may appoint proxies and must lodge proxy forms at Tricor Investor Services Limited or submit electronically no later than 48 hours before the meeting.
Board Composition (current): – Executive Directors: Mr. Kong Muk Yin, Mr. Guo Meibao – Non-Executive Directors: Mr. Lee Seng Hui (Chairman), Mr. Mark Wong Tai Chun, Mr. Zhou Haiying, Mr. Gao Zhaoyuan, Ms. Zhang Yuanyuan – Independent Non-Executive Directors: Dr. Xia Xiaoning, Dr. Wong Wing Kuen, Albert, Ms. Yang Lai Sum, Lisa, Mr. Cao Dan
No immediate plans to issue new securities or repurchase shares have been disclosed; the mandates are sought to maintain board flexibility within the prescribed limits.